Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

The Smidt Heart Institute at Cedars-Sinai has earned a prestigious designation for its excellence in adult and pediatric extracorporeal membrane oxygenation

News | ECMO Systems

Smidt Heart Institute’s ECMO Expertise Awarded

September 13, 2023 — The Smidt Heart Institute at Cedars-Sinai has earned a prestigious designation for its excellence ...

September 13, 2023

The analysis of the health records found that, on average, participants’ systolic blood pressure increased by up to 1.7 mm Hg in the winter months compared to the summer months

News | Hypertension

Study from AHA Hypertension Scientific Sessions Reports on Cold Weather’s Impact on Treating High Blood Pressure

September 13, 2023 — Blood pressure among patients diagnosed with hypertension appeared to slightly increase, and rates ...

September 13, 2023

Mineralys Therapeutics, Inc. has presented final results from the Target-HTN Phase 2 trial of lorundrostat, a highly selective aldosterone synthase inhibitor, in individuals with uncontrolled hypertension (uHTN) and resistant hypertension (rHTN).

News | Cardiovascular Clinical Studies

Mineralys Therapeutics Presents Target-HTN Phase 2 Trial Results at 2023 AHA Hypertension Scientific Sessions

September 12, 2023 — Mineralys Therapeutics, Inc. has presented final results from the Target-HTN Phase 2 trial of ...

September 12, 2023

The global interventional cardiology device market is driven by the number of procedures performed across the globe

Feature | Cardiovascular Business | By Emily Gilbert and Kamran Zamanian, PhD

The New Interventional Cardiology Market

The global interventional cardiology device market is driven by the number of procedures performed across the globe. The ...

September 12, 2023

UCLA-led research finds that among adult congenital heart disease (CHD) transplant recipients, single-ventricle physiology correlated with higher short-term mortality

News | Congenital Heart

UCLA Research Suggests that Heart Transplantation is Safer for Adults with Single-ventricle CHD than Previously Thought

September 12, 2023 — UCLA-led research finds that among adult congenital heart disease (CHD) transplant recipients ...

September 12, 2023

Premier cardiovascular digital health experience continues cultivating a community to examine and solve for future complex healthcare needs

News | Cardiovascular Business

HRX 2023 Conference Propelling the Future of Digital Health

September 11, 2023 — The Heart Rhythm Society (HRS) is gearing up for its second annual HRX event, bringing ...

September 11, 2023

Regulatory and quality leader brings decades of global SaMD experience to guide leading AI-powered cardiovascular diagnostic company through growth and expansion

News | Cardiovascular Business

Elucid Appoints Windi Hary to Lead Regulatory Affairs and Quality Management

September 11, 2023 — Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging ...

September 11, 2023

the Company is exploring development of a new Phase III clinical trial protocol

News | Heart Failure

BioCardia Announces Clarification and Next Steps on its Autologous CardiAMP Cell Therapy Programs

September 8, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

September 08, 2023

Patients of African ancestry with dilated cardiomyopathy (DCM) are less likely to have clinically actionable variants in DCM genes than those of European ancestry

News | Cardiovascular Clinical Studies

Study Highlights Need for Diversity in Clinical Trials to Better Understand, Treat Inherited Heart Muscle Disease

September 8, 2023 — Patients of African ancestry with dilated cardiomyopathy (DCM) are less likely to have clinically ...

September 08, 2023

New stroke risk reduction therapy with thromboresistant coating is designed to advance procedural performance and safety

News | Left Atrial Appendage (LAA) Occluders

Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device

September 7, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration approval ...

September 07, 2023

Recipient of the Harry Goldblatt Award for New Investigators from the American Heart Association’s 2023 Hypertension Council

News | Hypertension

Faulkner to be Honored by American Heart Association

September 7, 2023 —Jessica Faulkner, PhD, a physiologist whose research is focused on sex differences in cardiovascular ...

September 07, 2023

Vektor Medical has announced the release of a series of software enhancements to its AI-based non-invasive solution, vMap, which were designed to improve ablation outcomes and procedural efficiencies.

News | Artificial Intelligence

Vektor Medical Announces Enhanced AI-based vMap for Improved Cardiac Ablation Outcomes, Non-Invasive Mapping of Cardiac Arrhythmias

September 7, 2023 — Vektor Medical, developer of the only technology to accurately map arrhythmias using just 12-lead ...

September 07, 2023

The diagnosed severity of aortic stenosis strongly correlates with clinical outcomes, new Kaiser Permanente research shows

News | Structural Heart

Large Kaiser Permanente Study Could Lead to Better Management for Patients with Aortic Stenosis

September 6, 2023 — The diagnosed severity of aortic stenosis strongly correlates with clinical outcomes, new Kaiser ...

September 06, 2023

Updated AI-based software is designed to improve cardiac ablation outcomes and procedural efficiencies

News | ECG

Vektor Medical Unveils Enhanced vMap Technology for Accurate, Non-invasive Mapping of Cardiac Arrhythmias

September 6, 2023 — Vektor Medical, developer of the only technology to accurately map arrhythmias using just 12-lead EC ...

September 06, 2023

Magenta Medical, developer of the Elevate heart pump system, an FDA Designated Breakthrough Device, recently announced the completion of its FDA-approved Early Feasibility Study for the high-risk percutaneous coronary intervention (HR-PCI) indication.

News | Cardiovascular Clinical Studies

Magenta Medical Completes Enrollment to Early Feasibility Study for World’s Smallest Heart Pump

September 6, 2023 — Magenta Medical, developer of the Elevate heart pump system, an FDA Designated Breakthrough Device ...

September 06, 2023